The overall goal of Core C is to provide support for the research training and education mission of the MDCRC. In particular, Core C will support a Medical Student Fellowship, a Postdoctoral Fellowship and a two-day symposium to educate/engage patients and patient advocates. Both the medical student and postdoctoral fellow will have mentoring from the two core directors. This training effort is vital, so that there are basic scientists and qualified clinicians who can partner to test novel potential treatments. We are particularly interested in training the next generation of neurologists in muscular dystrophy translational research and thus have created the Medical Student Fellowship. This full-time fellowship will enable one medical student per year to be involved in all aspects of research in the MDCRC. The student will participate in the care of patients in the muscular dystrophy clinic and in the evaluation of patients participating in Project 2 under the supervision of Katherine Mathews. They will evaluate muscle biopsies with Steve Moore and study patient cells in Kevin Campbell's lab. Finally, they will present their findings from interesting cases at the Muscle Disease Neuropathology Conference once a month. To promote the development of basic scientists doing translational research in muscular dystrophy, the Postdoctoral Research Fellowship will provide an intensive translational research experience in the MDCRC for a PhD, MD or MD/PhD graduate in Kevin Campbell's laboratory. This research fellow will also observe patient care in the clinic and research settings to enhance their understanding of the clinical side of translational research. Finally, the lowa MDCRC will continue its tradition of involving patients and patient advocates in the center. Core C will host a two day symposium and Center open house with patients and their families. The goal of the symposium will be to educate the patients about the ongoing translational research in the MDCRC and provide a forum where their questions concerning translational research can be answered. The Medical Student and Postdoctoral Research fellows will participate in this symposium. Thus, this core will accelerate the education mission of the MDCRC and establish a training environment for clinician scientists.
Core C will coordinate the research training and education mission of the MDCRC. We are particularly interested in training the next generation of pediatric neurologists and thus have created a fellowship that will attract medical students interested in neurology. This fellowship will enable one medical student per year to perform translational research in the Center and to participate in the care of muscular dystrophy patients.
|Bönnemann, Carsten G; Wang, Ching H; Quijano-Roy, Susana et al. (2014) Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 24:289-311|
|Inamori, Kei-ichiro; Willer, Tobias; Hara, Yuji et al. (2014) Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of ?-dystroglycan in cells and tissues. J Biol Chem 289:28138-48|
|Chauveau, Claire; Bonnemann, Carsten G; Julien, Cedric et al. (2014) Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet 23:980-91|
|Wallace, Stephanie E; Conta, Jessie H; Winder, Thomas L et al. (2014) A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscul Disord 24:312-20|
|Willer, Tobias; Inamori, Kei-Ichiro; Venzke, David et al. (2014) The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated ?-dystroglycan functional glycosylation. Elife 3:|
|Crockett, Cameron D; Ruggieri, Alessandra; Gujrati, Meena et al. (2014) Late adult-onset of X-linked myopathy with excessive autophagy. Muscle Nerve 50:138-44|
|Goddeeris, Matthew M; Wu, Biming; Venzke, David et al. (2013) LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 503:136-40|
|Cirak, Sebahattin; Foley, Aileen Reghan; Herrmann, Ralf et al. (2013) ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain 136:269-81|
|Yang, Amy C; Ng, Bobby G; Moore, Steven A et al. (2013) Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Mol Genet Metab 110:345-51|
|Stevens, Elizabeth; Carss, Keren J; Cirak, Sebahattin et al. (2013) Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of *-dystroglycan. Am J Hum Genet 92:354-65|
Showing the most recent 10 out of 47 publications